Bilastine:Method Development and Validation

Bilastine: Method development and Validation deals with the development of a new simple, rapid, specific, accurate and precise UV spectrophotometric method for Active Pharmaceutical Ingredient (API) and in pharmaceutical dosage form. The validation of the proposed method was carried out according to the I.C.H guidelines. Bilastine being a new second generation H1histamine has shown beneficial action in treatment of many allergic conditions. Validation parameters covering all the qualitative and quantitative estimation of the drugs are mentioned along with the acceptance criteria as mentioned in the guidelines of the ICH.

Autorentext

Abhishek Chandola erhielt 2019 seinen B-Pharm-Abschluss vom Shri Guru Ram Rai Institute of Technology and Sciences, Dehradun, Uttarakhand. Er hat seinen M-Pharm in pharmazeutischer Qualitätssicherung von der School of Pharmaceutical Sciences der Shri Guru Ram Rai University, Dehradun, abgeschlossen. Uttarakhand im Jahr 2021.